The emerging role of atypical pathogens in community-acquired pneumonia

Area of Science:

• Infectious Diseases
• Pulmonology
• Microbiology

Background:

• Community-acquired pneumonia (CAP) is a significant cause of illness and death.
• Streptococcus pneumoniae is the most common cause, but atypical pathogens are increasingly recognized.
• Atypical pathogens, including Mycoplasma pneumoniae, Legionella, and Chlamydia, cause a spectrum of illness and affect all age groups.

Purpose of the Study:

• To highlight the growing importance of atypical pathogens in CAP.
• To emphasize their role in severe and mixed infections.
• To underscore the need for considering atypical pathogens in empiric treatment strategies.

Main Methods:

• Review of current literature and clinical observations regarding CAP etiology.
• Analysis of the clinical presentations and diagnostic challenges associated with atypical pathogens.
• Evaluation of antimicrobial treatment recommendations.

Main Results:

• Atypical pathogens are implicated in up to 40% of CAP cases.
• They can cause severe illness and are often co-pathogens in mixed infections, associated with high mortality.
• Laboratory detection is slow, and clinical differentiation from typical CAP is difficult.

Conclusions:

• Empiric antimicrobial therapy targeting atypical pathogens is crucial for CAP management.
• Agents like macrolides, fluoroquinolones, tetracyclines, and ketolides should be considered.
• Accurate prediction of etiology solely on clinical or radiologic grounds is not feasible.